Livforsakringsbolaget Skandia’s Alnylam Pharmaceuticals ALNY Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$325K	Hold	1,000	–	–	0.01%	309
2025 Q1	$270K	Hold	1,000	–	–	0.02%	331
2024 Q4	$235K	Hold	1,000	–	–	0.01%	366
2024 Q3	$275K	Buy	1,000 +800	+400%	+$220K	0.01%	357
2024 Q2	$48.6K	Hold	200	–	–	﹤0.01%	389
2024 Q1	$29.9K	Hold	200	–	–	﹤0.01%	462
2023 Q4	$38.3K	Hold	200	–	–	﹤0.01%	426
2023 Q3	$35.4K	Hold	200	–	–	﹤0.01%	371
2023 Q2	$38K	Hold	200	–	–	﹤0.01%	374
2023 Q1	$40.1K	Hold	200	–	–	﹤0.01%	366
2022 Q4	$47.5K	Hold	200	–	–	0.01%	335
2022 Q3	$40K	Sell	200 -600	-75%	-$120K	﹤0.01%	350
2022 Q2	$117K	Sell	800 -1,100	-58%	-$161K	0.01%	435
2022 Q1	$310K	Hold	1,900	–	–	0.02%	362
2021 Q4	$322K	Hold	1,900	–	–	0.02%	379
2021 Q3	$359K	Hold	1,900	–	–	0.02%	396
2021 Q2	$322K	Buy	1,900 +600	+46%	+$102K	0.02%	462
2021 Q1	$184K	Hold	1,300	–	–	0.01%	482
2020 Q4	$169K	Hold	1,300	–	–	0.01%	475
2020 Q3	$189K	Hold	1,300	–	–	0.02%	401
2020 Q2	$193K	Hold	1,300	–	–	0.02%	394
2020 Q1	$142K	Hold	1,300	–	–	0.02%	403
2019 Q4	$150K	Buy	1,300 +500	+63%	+$57.7K	0.02%	409
2019 Q3	$64K	Hold	800	–	–	0.01%	588
2019 Q2	$58K	Hold	800	–	–	0.01%	587
2019 Q1	$75K	Hold	800	–	–	0.01%	551
2018 Q4	$58K	Hold	800	–	–	0.01%	568
2018 Q3	$70K	Sell	800 -1,200	-60%	-$105K	0.01%	620
2018 Q2	$197K	Hold	2,000	–	–	0.02%	509
2018 Q1	$238K	Buy	2,000 +700	+54%	+$83.3K	0.02%	456
2017 Q4	$165K	Buy	+1,300	New	+$165K	0.02%	534
2016 Q4	–	Sell	-15,100	Closed	-$294K	–	689
2016 Q3	$294K	Buy	15,100 +7,800	+107%	+$152K	0.01%	657
2016 Q2	$405K	Hold	7,300	–	–	0.02%	640
2016 Q1	$458K	Hold	7,300	–	–	0.02%	626
2015 Q4	$687K	Hold	7,300	–	–	0.03%	530
2015 Q3	$587K	Hold	7,300	–	–	0.03%	558
2015 Q2	$875K	Buy	+7,300	New	+$875K	0.04%	500